Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      USFDA approves Vosevi for Hepatitis C

      USFDA approves Vosevi for Hepatitis C

      Ruby Khatun Khatun20 July 2017 9:25 AM IST
      The U.S. Food and Drug Administration (FDA) approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis...
      Sahyadri Hospital reuses catheters, FDA issues notice

      Sahyadri Hospital reuses catheters, FDA issues notice

      Ruby Khatun Khatun19 July 2017 11:39 AM IST
      Pune: The officials of Food and Drug Administration (FDA ) in their special inspection last month found that well-known Sahyadri Multi-Speciality...
      FDA approves new treatment to reduce the risk of breast cancer returning

      FDA approves new treatment to reduce the risk of breast cancer returning

      Ruby Khatun Khatun19 July 2017 9:50 AM IST
      The U.S. Food and Drug Administration (FDA) approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast...
      Alembic Pharma gets USFDA nod for anti hypertensive tablets

      Alembic Pharma gets USFDA nod for anti hypertensive tablets

      Ruby Khatun Khatun19 July 2017 9:35 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals on Tuesday said it has received approval from the US health regulator for generic Olmesartan Medoxomil...
      QNET Launches Ayurvedic Diabetes Management Supplement in India

      QNET Launches Ayurvedic Diabetes Management Supplement in India

      Ruby Khatun Khatun19 July 2017 9:34 AM IST
      New Delhi: Direct selling company QNET has launched Nutriplus Nature Diabahealth, a health supplement with proprietary Ayurvedic formulation to help...
      Indian Pharma exports to USA may go up in 2017-18: Report

      Indian Pharma exports to USA may go up in 2017-18: Report

      Ruby Khatun Khatun19 July 2017 9:32 AM IST
      Hyderabad: Despite pricing pressure and stiff competition, the Indian Pharma exports to the USA may go up in 2017-18 as USD 50 billion worth of drugs...
      Amazing opportunities for start-ups in heatlh care: GV Prasad

      Amazing opportunities for start-ups in heatlh care: GV Prasad

      Ruby Khatun Khatun19 July 2017 9:30 AM IST
      Hyderabad: There are "amazing" growth opportunities for start-ups in the health care sector in India in terms of technology and patient-centric...
      KKR picks up 49 per cent in Radiant Life Care for 200 million dollar

      KKR picks up 49 per cent in Radiant Life Care for 200 million dollar

      Ruby Khatun Khatun18 July 2017 10:30 AM IST
      Mumbai: Global private equity major KKR has agreed to invest USD 200 million for a 49 per cent stake in the Abhay Soi-run hospital management firm...
      Indian pharma firms need to increase research and development investment: Report

      Indian pharma firms need to increase research and development investment: Report

      Ruby Khatun Khatun18 July 2017 10:00 AM IST
      New Delhi: Indian pharma firms need to increase investments in research and development and quality of manufacturing to comply with global regulatory...
      Cipla looks out for marketing tie-up with Novartis

      Cipla looks out for marketing tie-up with Novartis

      Ruby Khatun Khatun18 July 2017 9:53 AM IST
      MUMBAI: Cipla, and Novartis are looking at the possibilities to jointly market asthma drug Xolair (omalizumab) an injectable prescription medicine...
      GST will benefit Ayurvedic industry in the long run: Kairali Ayurvedic Group

      GST will benefit Ayurvedic industry in the long run: Kairali Ayurvedic Group

      Ruby Khatun Khatun18 July 2017 9:53 AM IST
      New Delhi: Hailing the Goods and Services Tax (GST) imposed by the Centre from July 1, Executive Director Kairali Ayurvedic Group Abhilash K Ramesh...
      Janssen Wins FDA Approval of Tremfya (Guselkumab) for the treatment of Plaque Psoriasis

      Janssen Wins FDA Approval of Tremfya (Guselkumab) for the treatment of Plaque Psoriasis

      Ruby Khatun Khatun18 July 2017 9:53 AM IST
      Horsham, PA: Janssen Biotech, Inc. (Janssen) announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA™ (guselkumab) for the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok